The estimated Net Worth of Christopher K. Scott is at least $5.88 Milione dollars as of 11 February 2022. Mr Scott owns over 19,286 units of Iradimed Corp stock worth over $640,805 and over the last 10 years he sold IRMD stock worth over $4,899,199. In addition, he makes $340,265 as COO e CFO & Sec. at Iradimed Corp.
Mr has made over 13 trades of the Iradimed Corp stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 19,286 units of IRMD stock worth $965,457 on 11 February 2022.
The largest trade he's ever made was selling 96,250 units of Iradimed Corp stock on 6 August 2018 worth over $2,507,313. On average, Mr trades about 6,890 units every 49 days since 2014. As of 11 February 2022 he still owns at least 13,710 units of Iradimed Corp stock.
You can see the complete history of Mr Scott stock trades at the bottom of the page.
Christopher K. Scott is the COO, CFO & Sec. at Iradimed Corp.
As the COO e CFO & Sec. of Iradimed Corp, the total compensation of Mr Scott at Iradimed Corp is $340,265. There are 3 executives at Iradimed Corp getting paid more, with Chris Scott having the highest compensation of $587,753.
Mr Scott is 51, he's been the COO e CFO & Sec. of Iradimed Corp since . There are 7 older and 1 younger executives at Iradimed Corp. The oldest executive at Iradimed Corp is Anthony Vuoto, 69, who is the Independent Director.
Christopher's mailing address filed with the SEC is C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS, FL, 32708.
Over the last 10 years, insiders at Iradimed Corp have traded over $124,402,085 worth of Iradimed Corp stock and bought 103,100 units worth $734,768 . The most active insiders traders include Roger E. Susi, James B Hawkins e Brent Johnson. On average, Iradimed Corp executives and independent directors trade stock every 13 days with the average trade being worth of $812,855. The most recent stock trade was executed by Monty K Allen on 3 June 2024, trading 1,947 units of IRMD stock currently worth $84,441.
iradimed corporation develops, manufactures, markets, and distributes magnetic resonance imaging (mri) compatible medical devices, and related accessories and services in the united states and internationally. it offers mri compatible intravenous (iv) infusion pump system with associated disposable iv tubing sets; and mri compatible patient vital signs monitoring system. the company also provides iv poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and spo2 monitoring with sensors and accessories. it serves hospitals, acute care facilities, and outpatient imaging centers. the company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. iradimed corporation was incorporated in 1992 and is headquartered in winter springs, florida.
Iradimed Corp executives and other stock owners filed with the SEC include: